Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

671.18
+9.191.39%
Number of Gainers:93
Number of Losers:52
Number of Flat:8
PE:- -
High:673.52
Open:662.15
Low:661.43
Close:662.00
Volume:287.29M
Turnover:7.82B
Market Cap:464.24B
Float Cap:356.88B

Loading ...

Moving iMage Q4 Revenue USD 4.545 Million

Reuters
·
Sep 28

Moving iMage FY26 Net Loss Narrows 69% to USD 297,000; Net Sales Fall 4.6% to USD 17.32 Million

Reuters
·
Sep 28

Moving Image Q4 Net Income USD -296 Thousand

THOMSON REUTERS
·
Sep 28

Market Chatter: Citi Taps Coinbase to Enable Stablecoin Payments for Clients

MT Newswires Live
·
Sep 28

SHF Holdings announces board approved 1-for-12 reverse stock split

TIPRANKS
·
Sep 28

Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial

TIPRANKS
·
Sep 28

Phillips Edison Schedules Third-Quarter Earnings Conference Call

Reuters
·
Sep 28

TransCode Says Phase 1a Trial Shows 71.4% Stable Disease Rate for TTX-MC138 in Advanced Solid Tumors

Reuters
·
Sep 28

Transcode Reports Continued Disease Stabilization and Extended Treatment Duration with Ttx-Mc138 in Ongoing Phase 1a Clinical Trial Follow-up

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - Three Patients Remain Progression-Free at One Year

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - no Dose-Limiting Toxicities Reported Across Evaluated Dose Levels

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - 57.1% Disease Control Rate Through Three Months of Therapy

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - 71.4% Stable Disease Rate in 14 Efficacy-Evaluable Patients

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - Primary Endpoint of Phase 1a Study Met

THOMSON REUTERS
·
Sep 28

Safe Harbor Financial Implements 1-for-12 Reverse Stock Split on Sept. 30

Reuters
·
Sep 28

Reverse Stock Split Expected to be Effective September 30, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 28

Safe Harbor Financial Announces the Implementation of a Reverse Stock Split

THOMSON REUTERS
·
Sep 28

Approves Reverse Stock Split at 1-for-12 Ratio

THOMSON REUTERS
·
Sep 28

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

GlobeNewswire
·
Sep 28

Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards

GlobeNewswire
·
Sep 28